It is currently 18 Jun 2019 00:09

All times are UTC + 5:30 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: 20 Mar 2017 23:56 
Offline
User avatar

Joined: 26 Feb 2013 10:59
Posts: 642
A private drug company has developed an experimental cancer drug that has produced apparently “extraordinary” results, with a third of very ill lymphoma patients showing no signs of the disease after a single treatment.

The patients had non-Hodgkin lymphoma and all other treatments had failed. Normally they could expect to live for about six months. Nearly nine months later, more than a third showed no sign of the disease and more than half were still alive. However the company, Kite Pharma, cautioned that its version of CAT-T cell therapy may have also killed two of the 101 people in the study.

The treatment uses gene therapy to prompt the patient’s blood cells to attack cancer. In total 82 per cent of patients saw their tumours shrink by half or more at some point in the study. Dr Fred Locke, a blood cancer expert at Moffitt Cancer Centre in Tampa, Florida, who co-led the study and was a paid adviser to Kite, stressed the patients in the study had had few other choices left. “The numbers are fantastic,” he said. “These are heavily treated patients who have no other options.”

The drug was developed at the US National Cancer Institute and then licensed to Kite. 
The results were released by the company and have not been published or reviewed by other experts. Full results will be presented at the American Association for Cancer Research conference in April. The company plans to seek approval from the US Food and Drug Administration by the end of March and in Europe later this year.

Experts say results are promising but caution further research is needed to establish if the cancer will return; the side-effects may also include a small risk of death.

A 43 year old patient from Orlando, credited the treatment with saving his life.  He had been told his cancer was getting worse and his treatment was failing. He had CAR-T therapy and subsequently saw his tumours “shrink like ice cubes”. He is now in complete remission. “They were able to save my life,” Mr Padilla said.

And independent expert, Dr Roy Herbst, cancer medicines chief at the Yale Cancer Centre, was taken aback by the treatment’s success. “This seems extraordinary … extremely encouraging,” he said.
However Dr Herbst said further studies were needed to see if the benefit of the treatment was lasting or if the patients’ cancer returned.


Reported by Ian Johnston in The Independent


Top
 Profile Send private message  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC + 5:30 hours [ DST ]


Who is online

Users browsing this forum: No registered users and 1 guest


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Jump to:  
cron